Dr. Zhonglin Hao
Claim this profileUniversity of Kentucky/Markey Cancer Center
Studies Lung Cancer
Studies Small Cell Lung Cancer
11 reported clinical trials
26 drugs studied
Area of expertise
1Lung Cancer
Stage IV
EGFR positive
2Small Cell Lung Cancer
Affiliated Hospitals
Clinical Trials Zhonglin Hao is currently running
ONC-392 vs Chemotherapy
for Lung Cancer
This trial is testing gotistobart, a new drug that helps the immune system fight advanced lung cancer in patients who haven't responded to other treatments. It works by blocking a protein that allows cancer cells to hide from the immune system.
Recruiting2 awards Phase 310 criteria
Tazemetostat + Topotecan + Pembrolizumab
for Small Cell Lung Cancer
This phase I trial tests the safety, side effects, and best dose of tazemetostat in combination with topotecan and pembrolizumab in treating patients with small cell lung cancer that has come back after a period of improvement (recurrent). Tazemetostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as topotecan, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving tazemetostat in combination with topotecan and pembrolizumab may shrink or stabilize recurrent small cell lung cancer.
Recruiting1 award Phase 119 criteria
More about Zhonglin Hao
Clinical Trial Related5 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Zhonglin Hao has experience with
- Durvalumab
- Topotecan Hydrochloride
- Atezolizumab
- Copanlisib
- Docetaxel
- ONC-392
Breakdown of trials Zhonglin Hao has run
Lung Cancer
Small Cell Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Zhonglin Hao specialize in?
Zhonglin Hao focuses on Lung Cancer and Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are EGFR positive.
Is Zhonglin Hao currently recruiting for clinical trials?
Yes, Zhonglin Hao is currently recruiting for 5 clinical trials in Lexington Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Zhonglin Hao has studied deeply?
Yes, Zhonglin Hao has studied treatments such as Durvalumab, Topotecan Hydrochloride, Atezolizumab.
What is the best way to schedule an appointment with Zhonglin Hao?
Apply for one of the trials that Zhonglin Hao is conducting.
What is the office address of Zhonglin Hao?
The office of Zhonglin Hao is located at: University of Kentucky/Markey Cancer Center, Lexington, Kentucky 40536 United States. This is the address for their practice at the University of Kentucky/Markey Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.